Thank you very much.
The Auditor General's report indicates that the department has limited regulatory power when it comes to modifying the labelling of drugs after they have been authorized for sale.
I would like you to explain a little about why this power is limited, what that means exactly. Would it be better for the department to have more power in that respect?